IMARC Group, a leading market research company, has recently releases report titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global point-of-care diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the point-of-care diagnostics market?
The global point-of-care diagnostics market size reached US$ 45.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.96% during 2023-2028.
What is point-of-care diagnostics?
Point-of-care (PoC) diagnostics represent medical testing that enables quick analysis and receives immediate results. It comprises numerous portable instruments for glucose handling and infectious disorders, cardiometabolic and urinalysis testing, among others. PoC testing aids in the early diagnosis of critical illnesses, thus offering an enhanced patient-centric approach to healthcare. In addition, it is widely used for supplying diagnostic facilities to distant locations where it is difficult to set up clinical laboratories. Therefore, PoC testing essentials are incorporated with medical vehicles, including air ambulances, airplanes, helicopters, and spacecraft.
Get the Free PDF Sample Report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample
Point-of-Care Diagnostics Market Trends and Growth Drivers:
The expanding geriatric population and the increasing occurrence of chronic diseases that lead to increased morbidity and mortality rates are among the key factors driving the point-of-care diagnostics market. Moreover, the widespread adoption of PoC devices to diagnose infectious disorders, such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), malaria, dengue fever, and influenza, require immediate screening, is also stimulating the market growth. Besides this, several technological advancements, including the development of miniaturized devices, are acting as significant growth-inducing factors.
Furthermore, the integration of PoC devices with wireless technology has enabled healthcare professionals to maintain electronic medical records (EMR), which is further propelling the global market. Apart from this, the introduction of home-testing cancer kits that can actively monitor and analyze tumor cells is positively influencing the market growth. Additionally, extensive research and development (R&D) activities to develop molecular diagnostic devices and the increasing awareness for early detection of diseases are anticipated to fuel the point-of-care diagnostics market over the forecasted period.
TopPoint-of-care Diagnostics companies covered:
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- Pts Diagnostics
- Qiagen
- Siemens
- Trinity Biotech
Explore Full Report Description At: https://www.imarcgroup.com/point-of-care-diagnostics-market
POC Diagnostics Market Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Breakup by Platform:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Breakup by Prescription Mode:
- Prescription-Based Testing
- OTC Testing
Breakup by End-User:
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696
